Effects of Phosphate-lowering Agents in Non-Dialysis Chronic Kidney Disease MD Editorial Team27 Oct 2021 9:00 AM ISTThe effects of phosphate-lowering treatments on clinical outcomes in individuals with chronic kidney disease (CKD) are unknown; systematic studies...
Lower LDL-C associated with low risk of CKD progression, finds study Dr Kartikeya Kohli22 Oct 2021 10:00 AM ISTKorea: According to a recent study, there is a graded connection between LDL-C and the probability of poor cardiovascular outcomes in patients with...
Canagliflozin reduces hyperkalemia risk in patients with diabetes and CKD: CREDENCE trial MD Editorial Team20 Oct 2021 9:00 AM ISTAustralia: Hyperkalemia is common in people with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD), and it is associated with the...
Exposure to pesticide Malathion linked to chronic kidney disease, finds study Hina Zahid16 Oct 2021 9:00 AM ISTA commonly available pesticide has been associated with an increased risk of chronic kidney disease (CKD) in a University of Queensland...
Bariatric surgery and weight loss halt progression of CKD, finds study MD Editorial Team8 Oct 2021 9:00 AM ISTObesity affects 93.3 million adults in the United States. Bariatric surgery has been associated with a 58% reduction in the risk of proteinuria and...
Urate lowering agents don't slow progression of CKD in hyperuricemia, finds study MD Editorial Team7 Oct 2021 10:12 PM ISTHyperuricemia is very common in CKD patients because of reduced urinary excretion of uric acid. The role of uric acid in the development CKD and...
Treating Resistant Hypertension in CKD patients- A Double challenge for physicians Dr. Prem Aggarwal7 Oct 2021 12:24 PM ISTResistant hypertension (RH), identified as the inability to achieve a target blood pressure despite the use of three or more maximally dosed...
Dapagliflozin reduces albuminuria in CKD patients with or without diabetes: Lancet study Medha Baranwal7 Oct 2021 10:30 AM ISTUSA: A prespecified analysis from the DAPA-CKD trial has found that the SGLT2 inhibitor dapagliflozin significantly reduces albuminuria in patients...
Anemia, AF and hyperuricemia identified as risk factors for new onset CKD: Study MD Editorial Team6 Oct 2021 7:47 PM ISTDiabetes and cardiovascular diseases are most common causes of onset of kidney disease.Various risk factors have been identified for the new onset or...
Laxatives improve hyperkalemia in CKD patients but not in dialysis patients: Study MD Editorial Team30 Sept 2021 9:00 AM ISTMemphis, TN: A recent study published in the Journal of the American Society of Nephrology reported that laxative use may lower the risk of...
Patiromer prolongs use of spironolactone independently of diabetes status: Study MD Editorial Team27 Sept 2021 9:00 AM ISTSpironolactone is recommended in patients with resistant hypertension. A new clinical trial AMBER by Dr Rajiv Agarwal, and team reported that...
Magnesium supplementation improves mineral bone disorder in dialysis patients: Study MD Editorial Team21 Sept 2021 9:00 AM ISTChina: Guangying Guo and colleagues have found in a new study that Magnesium (Mg) supplementation alone might ameliorate chronic kidney...
